N.N. Blokhin National Medical Research Center of Oncology
1 clinical trials · Sponsor
◉ Watch N.N. Blokhin National Medical Research Center of Oncology
| Record | Firm | Date |
|---|---|---|
| Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy (NCT05314296) | N.N. Blokhin National Medical Research Center of Oncology | 2020-06-01 |
Track N.N. Blokhin National Medical Research Center of Oncology automatically
Every clearance here is in the API, with alerts when new ones post.